CytomX Therapeutics
CTMX
CTMX
111 hedge funds and large institutions have $561M invested in CytomX Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 40 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
111
Holders Change
-11
Holders Change %
-9.02%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
37
Reduced
40
Closed
26
Calls
$169K
Puts
$2K
Net Calls
+$167K
Net Calls Change
+$1.07M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$40.4M |
| 2 |
RI
RTW Investments
New York
|
$13.7M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$4.48M |
| 4 |
PA
Perceptive Advisors
New York
|
$43.6M |
| 5 |
AG
Artal Group
Luxembourg
|
$2.27M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FRM
126
Fox Run Management
Greenwich,
Connecticut
| – | -$225K | -12,149 | Closed |
|
|
OSAM
127
O'Shaughnessy Asset Management
Stamford,
Connecticut
| – | -$175K | -9,570 | Closed |
|
|
NIT
128
NumerixS Investment Technologies
Vancouver,
British Columbia, Canada
| – | -$82K | -4,500 | Closed |
|
129
Pacer Advisors
Malvern,
Pennsylvania
| – | -$82K | -4,431 | Closed |
|
|
QT
130
Quantbot Technologies
New York
| – | -$74K | -4,046 | Closed |
|
131
Walleye Trading
New York
| – | -$46K | -2,500 | Closed |
|
132
Schroder Investment Management Group
London,
United Kingdom
| – | -$44K | -2,366 | Closed |
|
|
GC
133
Grace Capital
Quincy,
Massachusetts
| – | -$35K | -1,888 | Closed |
|
|
MAM
134
Meeder Asset Management
Dublin,
Ohio
| – | -$34K | -1,764 | Closed |
|
|
PHK
135
Point72 Hong Kong
Hong Kong
| – | -$25K | -1,347 | Closed |
|
|
PCM
136
Prelude Capital Management
New York
| – | -$1K | -72 | Closed |
|
137
AssetMark Inc
Concord,
California
| – | -$1K | -44 | Closed |
|